A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life
- 1 April 2000
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 42 (4) , 653-659
- https://doi.org/10.1016/s0190-9622(00)90180-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitisBritish Journal of Dermatology, 1997
- The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimensBritish Journal of Dermatology, 1996
- The occurrence of atopic dermatitis in North Europe: An international questionnaire studyJournal of the American Academy of Dermatology, 1996
- Practical management of atopic eczemaThe Lancet, 1994
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994
- Cyclosporin in atopic dermatitis: a multicentre placebo-controlled studyBritish Journal of Dermatology, 1994
- WEIGHT-INDEPENDENT DOSING OF CYCLOSPORINE—AN ALTERNATIVE TO THE “mg/kg” DOCTRINETransplantation, 1994
- PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS—A CONCENTRATION-CONTROLLED COMPARISON WITH THE COMMERCIAL FORMULATIONTransplantation, 1994
- Maintenance treatment with cyclosporin in atopic eczemaBritish Journal of Dermatology, 1994
- Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisThe Lancet, 1991